These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17627490)

  • 41. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discrepancies regarding the quality of life of patients with Alzheimer's disease: a three-year longitudinal study.
    Conde-Sala JL; Turró-Garriga O; Garre-Olmo J; Vilalta-Franch J; Lopez-Pousa S
    J Alzheimers Dis; 2014; 39(3):511-25. PubMed ID: 24217273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone.
    Rabinowitz J; Katz I; De Deyn PP; Greenspan A; Brodaty H
    Int Psychogeriatr; 2007 Apr; 19(2):227-40. PubMed ID: 16879763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
    Wragg RE; Jeste DV
    Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study.
    Agüera-Ortiz L; Frank-García A; Gil P; Moreno A;
    Int Psychogeriatr; 2010 Dec; 22(8):1265-79. PubMed ID: 20849672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychosis and antipsychotic medications in Alzheimer's disease: clinical management and research perspectives.
    Sultzer DL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):78-90. PubMed ID: 14566100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 50. Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study.
    Logsdon RG; Teri L; Weiner MF; Gibbons LE; Raskind M; Peskind E; Grundman M; Koss E; Thomas RG; Thal LJ
    J Am Geriatr Soc; 1999 Nov; 47(11):1354-8. PubMed ID: 10573447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
    Ballard C; Banister C; Khan Z; Cummings J; Demos G; Coate B; Youakim JM; Owen R; Stankovic S;
    Lancet Neurol; 2018 Mar; 17(3):213-222. PubMed ID: 29452684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
    Clark WS; Street JS; Feldman PD; Breier A
    J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
    Devanand DP; Pelton GH; D'Antonio K; Strickler JG; Kreisl WC; Noble J; Marder K; Skomorowsky A; Huey ED
    Alzheimer Dis Assoc Disord; 2017; 31(1):73-75. PubMed ID: 27819842
    [No Abstract]   [Full Text] [Related]  

  • 54. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer's Disease: A Review of the Literature.
    McClam TD; Marano CM; Rosenberg PB; Lyketsos CG
    Harv Rev Psychiatry; 2015; 23(5):377-93. PubMed ID: 26332220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
    De Deyn PP; Eriksson H; Svensson H;
    Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 59. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
    Zaraa AS
    Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
    [No Abstract]   [Full Text] [Related]  

  • 60. Using risperidone for Alzheimer's dementia-associated psychosis.
    McNeal KM; Meyer RP; Lukacs K; Senseney A; Mintzer J
    Expert Opin Pharmacother; 2008 Oct; 9(14):2537-43. PubMed ID: 18778191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.